A multimodal approach to accelerate drug discovery and development in Alzheimer’s disease

Project description

Combining genetics and imaging for AD drug discovery

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• medical and health sciences › basic medicine › neurology › dementia › alzheimer
• natural sciences › computer and information sciences › data science › big data

Programme(s)

• H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme
• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Topic(s)

• MSCA-IF-2019 - Individual Fellowships

Call for proposal

H2020-MSCA-IF-2019

See other projects for this call

Funding Scheme

MSCA-IF-GF - Global Fellowships

Coordinator

INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE

Net EU contribution

€ 257 619,84

Address

Boulevard De L'hopital 47
75013 Paris
France

Region

Ile-de-France › Ile-de-France › Paris

Activity type

Research Organisations

Links

Other funding

€ 257 619,84

Partners (1)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY

United States

Net EU contribution

€ 0,00

Address

Serra Mall 450
94305 2004 Stanford

Activity type

Higher or Secondary Education Establishments

Links

Other funding

€ 0,00